These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 11567963)

  • 1. Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies.
    Poon AC; Geerling G; Dart JK; Fraenkel GE; Daniels JT
    Br J Ophthalmol; 2001 Oct; 85(10):1188-97. PubMed ID: 11567963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of persistent epithelial defects using autologous serum application].
    Alvarado Valero MC; Martínez Toldos JJ; Borras Blasco J; Almiñana Almiñana A; Pérez Ramos JM
    Arch Soc Esp Oftalmol; 2004 Nov; 79(11):537-42. PubMed ID: 15578282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease.
    Noble BA; Loh RS; MacLennan S; Pesudovs K; Reynolds A; Bridges LR; Burr J; Stewart O; Quereshi S
    Br J Ophthalmol; 2004 May; 88(5):647-52. PubMed ID: 15090417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ready-made allogeneic ABO-specific serum eye drops: production from regular male blood donors, clinical routine, safety and efficacy.
    Harritshøj LH; Nielsen C; Ullum H; Hansen MB; Julian HO
    Acta Ophthalmol; 2014 Dec; 92(8):783-6. PubMed ID: 24629028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of serum eye drops with hydrogel bandage contact lenses in the treatment of persistent epithelial defects.
    Schrader S; Wedel T; Moll R; Geerling G
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1345-9. PubMed ID: 16544115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autologous serum utilization in patients with lacrimal hyposecretion and persistent epithelial defects of cornea--clinical study].
    Nistor M; Nistor C
    Oftalmologia; 2005; 49(3):30-3. PubMed ID: 16408672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autologous serum for otherwise therapy resistant corneal epithelial defects - Prospective report on the first 70 eyes].
    Ferreira de Souza R; Kruse FE; Seitz B
    Klin Monbl Augenheilkd; 2001 Nov; 218(11):720-6. PubMed ID: 11731899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous serum eyedrops in the treatment of aniridic keratopathy.
    López-García JS; Rivas L; García-Lozano I; Murube J
    Ophthalmology; 2008 Feb; 115(2):262-7. PubMed ID: 17675158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous serum 50% eyedrops in the treatment of persistent corneal epithelial defects.
    Jeng BH; Dupps WJ
    Cornea; 2009 Dec; 28(10):1104-8. PubMed ID: 19730088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous serum eye drops for the treatment of persistent corneal epithelial defects.
    Arain MA; Dar AJ; Adeeb L
    J Coll Physicians Surg Pak; 2013 Oct; 23(10):737-9. PubMed ID: 24112261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of topical autologous serum on graft re-epithelialization after penetrating keratoplasty.
    Chen YM; Hu FR; Huang JY; Shen EP; Tsai TY; Chen WL
    Am J Ophthalmol; 2010 Sep; 150(3):352-359.e2. PubMed ID: 20579630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic outcomes of combined topical autologous serum eye drops with silicone-hydrogel soft contact lenses in the treatment of corneal persistent epithelial defects: A preliminary study.
    Lee YK; Lin YC; Tsai SH; Chen WL; Chen YM
    Cont Lens Anterior Eye; 2016 Dec; 39(6):425-430. PubMed ID: 27349951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of the ocular surface using hypotonic 0.4% hyaluronic acid drops in keratoconjunctivitis sicca.
    Iester M; Orsoni GJ; Gamba G; Taffara M; Mangiafico P; Giuffrida S; Rolando M
    Eye (Lond); 2000 Dec; 14(Pt 6):892-8. PubMed ID: 11584850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic serum eye drops for the treatment of persistent corneal epithelial defect.
    Chiang CC; Chen WL; Lin JM; Tsai YY
    Eye (Lond); 2009 Feb; 23(2):290-3. PubMed ID: 18188173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous serum eye drops diluted with 0.5% methylcellulose and 0.9% saline solution: a clinical comparative study.
    Neubauer N; Silveira VD; Locatelli CI; Marinho DR
    Arq Bras Oftalmol; 2023; 87(5):e20220064. PubMed ID: 39298725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of azithromycin and tobramycin eye drops on epithelial wound healing and tolerance after penetrating keratoplasty.
    Blavin J; Sauer A; Saleh M; Gaucher D; Speeg-Schatz C; Bourcier T
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):428-32. PubMed ID: 22420841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of superior limbic keratoconjunctivitis by application of autologous serum.
    Goto E; Shimmura S; Shimazaki J; Tsubota K
    Cornea; 2001 Nov; 20(8):807-10. PubMed ID: 11685056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of autologous serum tears in persistent corneal epithelial defects.
    Young AL; Cheng AC; Ng HK; Cheng LL; Leung GY; Lam DS
    Eye (Lond); 2004 Jun; 18(6):609-14. PubMed ID: 15184926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of persistent epithelial defects with single-dose autologous serum eye drops.
    Özbek-Uzman S; Yalnız-Akkaya Z; Şingar Özdemir E; Burcu A
    Eur J Ophthalmol; 2022 Jul; 32(4):2159-2165. PubMed ID: 34585599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells.
    Geerling G; Daniels JT; Dart JK; Cree IA; Khaw PT
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):948-56. PubMed ID: 11274071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.